###### 

Descriptive characteristics of participants at baseline and the change over the 12-month study

  Variable                            Intervention Baseline   Control Baseline   Intervention Δ from baseline   Control Δ from baseline   P (t effect)   P (g×t interaction)
  ----------------------------------- ----------------------- ------------------ ------------------------------ ------------------------- -------------- ---------------------
  Framingham 10-year risk (%)         19.6±6.6                21.2±8.9           −3.4±5.7                       −0.3±5.9                  0.013          0.033
  D:A:D 5-year risk (%)               6.4±5.9                 5.4±4.9            −1.4±3.1                       0.6±3.3                   NS             0.017
  Total cholesterol (mmol/L)          5.2±1.0                 4.9±1.1            −0.6±0.9                       0.0±0.9                   0.011          0.013
  High-density lipoprotein (mmol/L)   1.2±0.3                 1.2±0.3            0.5±0.2                        0.1±0.3                   NS             NS
  Systolic blood pressure (mmHg)      130±13                  132±12             −6.2±17.1                      −0.6±12.4                 NS             NS
  \% Body fat                         22.3±4.2                --                 −1.0±1.9                       --                        0.009          \-

Descriptive characteristics of participants at baseline and the change over the 12-month study programme. Mean±SD; NS, not significant.
